Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neuropeptides | 2 | 2019 | 91 | 0.88 | Why? |
| Enteric Nervous System | 1 | 2019 | 28 | 0.78 | Why? |
| Th2 Cells | 2 | 2018 | 680 | 0.70 | Why? |
| Neuroimmunomodulation | 1 | 2019 | 154 | 0.68 | Why? |
| Neurons | 1 | 2019 | 864 | 0.48 | Why? |
| Lymphocytes | 2 | 2018 | 3056 | 0.36 | Why? |
| Asthma | 3 | 2019 | 4383 | 0.29 | Why? |
| Immunity, Innate | 2 | 2018 | 6570 | 0.25 | Why? |
| Still's Disease, Adult-Onset | 1 | 2021 | 100 | 0.20 | Why? |
| Cellular Microenvironment | 1 | 2018 | 55 | 0.19 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 92 | 0.19 | Why? |
| Dermatomyositis | 1 | 2021 | 193 | 0.18 | Why? |
| Keratan Sulfate | 1 | 2016 | 2 | 0.17 | Why? |
| Disaccharides | 1 | 2016 | 23 | 0.17 | Why? |
| Prednisolone | 1 | 2020 | 443 | 0.16 | Why? |
| Antigens, Fungal | 1 | 2017 | 106 | 0.16 | Why? |
| Cell Communication | 1 | 2018 | 396 | 0.16 | Why? |
| Gonadal Steroid Hormones | 1 | 2018 | 328 | 0.15 | Why? |
| Hypersensitivity, Immediate | 1 | 2017 | 134 | 0.15 | Why? |
| Pulmonary Emphysema | 1 | 2016 | 122 | 0.15 | Why? |
| Homeostasis | 1 | 2018 | 582 | 0.14 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.11 | Why? |
| Allergens | 1 | 2017 | 728 | 0.11 | Why? |
| Air Microbiology | 1 | 2020 | 1322 | 0.10 | Why? |
| Pulmonary Fibrosis | 1 | 2020 | 1068 | 0.10 | Why? |
| Cytokines | 4 | 2018 | 15010 | 0.09 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.09 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.08 | Why? |
| Inflammation | 2 | 2019 | 13255 | 0.07 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.07 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.07 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.07 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.07 | Why? |
| Immunoglobulin E | 2 | 2017 | 557 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.07 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.06 | Why? |
| Animals | 4 | 2019 | 78931 | 0.06 | Why? |
| Lung | 2 | 2021 | 31049 | 0.06 | Why? |
| Pulmonary Diffusing Capacity | 1 | 2021 | 191 | 0.05 | Why? |
| Nitric Oxide | 2 | 2017 | 769 | 0.05 | Why? |
| Pneumonia | 2 | 2017 | 5652 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 245 | 0.05 | Why? |
| Nippostrongylus | 1 | 2017 | 2 | 0.05 | Why? |
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2017 | 4 | 0.05 | Why? |
| Receptors, Neurotransmitter | 1 | 2017 | 10 | 0.05 | Why? |
| Cholinergic Neurons | 1 | 2017 | 9 | 0.04 | Why? |
| Interleukin-9 | 1 | 2017 | 29 | 0.04 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Interleukin-5 | 1 | 2017 | 138 | 0.04 | Why? |
| Pancreatic Elastase | 1 | 2016 | 41 | 0.04 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2016 | 85 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Biomarkers, Pharmacological | 1 | 2017 | 150 | 0.04 | Why? |
| Adoptive Transfer | 1 | 2017 | 250 | 0.04 | Why? |
| RAW 264.7 Cells | 1 | 2016 | 316 | 0.04 | Why? |
| Interleukin-13 | 1 | 2017 | 204 | 0.04 | Why? |
| Sus scrofa | 1 | 2016 | 205 | 0.04 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2016 | 211 | 0.04 | Why? |
| Japan | 2 | 2020 | 6653 | 0.04 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.04 | Why? |
| Administration, Inhalation | 1 | 2021 | 1647 | 0.03 | Why? |
| Forced Expiratory Volume | 1 | 2017 | 632 | 0.03 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.03 | Why? |
| Eosinophilia | 1 | 2017 | 292 | 0.03 | Why? |
| Fungi | 1 | 2017 | 471 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2021 | 1755 | 0.03 | Why? |
| Humans | 13 | 2021 | 930598 | 0.03 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.03 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Pulmonary Alveoli | 1 | 2016 | 867 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Eosinophils | 1 | 2017 | 848 | 0.03 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.02 | Why? |
| Gastrointestinal Tract | 1 | 2017 | 1113 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2016 | 2309 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| New York City | 1 | 2021 | 7432 | 0.02 | Why? |
| Mice | 2 | 2017 | 21357 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2016 | 5542 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Dexamethasone | 1 | 2016 | 2055 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Male | 6 | 2021 | 367725 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Female | 6 | 2021 | 380317 | 0.02 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Smoking | 1 | 2016 | 3358 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Models, Biological | 1 | 2016 | 4907 | 0.01 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3832 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2016 | 10998 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Adult | 3 | 2021 | 244371 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Kabata's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(71)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_